STOCK TITAN

Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Shattuck Labs Chief Technical Officer Abhinav A. Shukla reported option-related trades in the company’s common stock. On June 30 and July 1, he exercised stock options covering a total of 23,465 shares at an exercise price of $3.57 per share.

The same total of 23,465 shares of common stock was sold in open-market transactions at weighted average prices of about $7.08 and $7.07 per share, under a pre-arranged Rule 10b5-1 trading plan intended to fund the option exercise price and estimated tax withholding. After these transactions, he directly holds 86,380 shares of common stock and continues to hold unexercised portions of an option covering up to 52,200 shares that vests through January 25, 2027.

Positive

  • None.

Negative

  • None.
Insider Shukla Abhinav A.
Role Chief Technical Officer
Sold 23,465 shs ($166K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 100 $0.00 --
Exercise Common Stock 100 $3.57 $357.00
Sale Common Stock 100 $7.07 $707.00
Exercise Stock Option (Right to Buy) 23,365 $0.00 --
Exercise Common Stock 23,365 $3.57 $83K
Sale Common Stock 23,365 $7.08 $165K
Holdings After Transaction: Stock Option (Right to Buy) — 26,703 shares (Direct, null); Common Stock — 86,480 shares (Direct, null)
Footnotes (1)
  1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
Shares sold 23,465 shares Open-market sales of common stock on June 30 and July 1, 2026
Sale prices $7.08 and $7.07 per share Weighted average prices for June 30 and July 1, 2026 sales
Options exercised 23,465 shares Common stock acquired via option exercises at $3.57 per share
Option exercise price $3.57 per share Exercise or conversion price for stock options
Shares held after 86,380 shares Direct common stock ownership after reported transactions
Option grant size 52,200 shares Total shares covered by the referenced stock option
Option expiration January 25, 2033 Expiration date for the stock option right to buy
Rule 10b5-1 trading plan regulatory
"Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above is a weighted average price. The shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
exercise or conversion of derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
tax withholding financial
"intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding"
Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.
vesting financial
"one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shukla Abhinav A.

(Last)(First)(Middle)
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200

(Street)
AUSTIN TEXAS 78701

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Shattuck Labs, Inc. [ STTK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technical Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M23,365A$3.57109,745D
Common Stock06/30/2026S(1)23,365D$7.08(2)86,380D
Common Stock07/01/2026M100A$3.5786,480D
Common Stock07/01/2026S(1)100D$7.0786,380D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$3.5706/30/2026M23,365 (3)01/25/2033Common Stock23,365$0.0026,803D
Stock Option (Right to Buy)$3.5707/01/2026M100 (3)01/25/2033Common Stock100$0.0026,703D
Explanation of Responses:
1. Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2026. The plan is intended to execute sales of shares received upon option exercise only as needed to fund the exercise price and estimated tax withholding associated with option exercises under the plan. Under the procedures of the administering broker, acquired shares are first sold to fund the aggregate exercise price and estimated tax withholding with respect to all possible option exercises in a particular order under the plan and only once fully funded will acquired shares be held by the Reporting Person.
2. The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3. This option represents a right to purchase a total of 52,200 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.
/s/ Andrew R. Neill, Attorney-in-fact for Abhinav A. Shukla07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did STTK executive Abhinav Shukla report?

Abhinav Shukla reported exercising stock options for 23,465 Shattuck Labs shares at $3.57 and selling the same number of shares in open-market trades at weighted average prices around $7.07–$7.08, as disclosed in the Form 4 filing.

How many STTK shares did the CTO sell and at what prices?

The CTO sold 23,465 shares of Shattuck Labs common stock. The sales were executed at weighted average prices of approximately $7.08 per share on June 30 and $7.07 per share on July 1, across multiple transactions within a disclosed price range.

Were Abhinav Shukla’s STTK share sales part of a 10b5-1 plan?

Yes. The filing states the sales were made under a Rule 10b5-1 trading plan adopted on February 2, 2026. The plan is designed to sell shares received from option exercises only as needed to cover exercise costs and estimated tax withholding obligations.

Did the Shattuck Labs CTO exercise stock options in this Form 4?

Yes. Abhinav Shukla exercised stock options to acquire a total of 23,465 Shattuck Labs common shares at an exercise price of $3.57 per share. These exercises reduced his outstanding option balance from a larger grant that originally covered 52,200 shares.

How many STTK shares does Abhinav Shukla hold after these transactions?

Following the reported option exercises and related sales, Abhinav Shukla holds 86,380 shares of Shattuck Labs common stock directly. He also continues to hold unexercised stock options from a 52,200-share grant that vests through January 25, 2027, subject to continued service.

What is the size and vesting schedule of the CTO’s STTK option grant?

The option grant referenced in the filing covers 52,200 shares of Shattuck Labs common stock. One quarter vested on January 25, 2024, and the remaining three quarters vest in equal monthly installments through January 25, 2027, conditioned on continued service to the company.